APA (7th ed.) Citation

J, H., & J, Y. (2026). The novel anticoagulant dabigatran versus enoxaparin for thromboprophylaxis following total hip replacement: A meta-analysis. BMC cardiovascular disorders, 26(1), . https://doi.org/10.1186/s12872-026-05585-3

Chicago Style (17th ed.) Citation

J, Huang, and Ye J. "The Novel Anticoagulant Dabigatran Versus Enoxaparin for Thromboprophylaxis Following Total Hip Replacement: A Meta-analysis." BMC Cardiovascular Disorders 26, no. 1 (2026). https://doi.org/10.1186/s12872-026-05585-3.

MLA (9th ed.) Citation

J, Huang, and Ye J. "The Novel Anticoagulant Dabigatran Versus Enoxaparin for Thromboprophylaxis Following Total Hip Replacement: A Meta-analysis." BMC Cardiovascular Disorders, vol. 26, no. 1, 2026, https://doi.org/10.1186/s12872-026-05585-3.